The Global Immunotherapy Market is set to grow rapidly through 2032, propelled by rising prevalence of cancer and autoimmune conditions, and breakthroughs like CAR‑T therapies, checkpoint inhibitors, therapeutic vaccines, and AI‑enhanced biologics design. Oncology remains the dominant application, while autoimmune and infectious disease segments are gaining momentum. North America cur... https://www.uniprismmarketresearch.com/verticals/healthcare/immunotherapy